2012-6-13 5:53:17
The study will recruit 250 healthy adults of 18 to 49 years old, and the outcome expected at the end of this year. The resulting data will help the VaxInnate determine appropriate doses of the vaccine for further development. http://translate.googleusercontent.com/translate_c?hl=en&ie=UTF8&prev=_t&rurl=translate.google.com&sl=auto&tl=en&twu=1&u=http://www.bioon.com/biopharm/525287.shtml&usg=ALkJrhgmxc-1dLn1t1RVhxVGgf0i5cx-5A
No comments:
Post a Comment